赛诺菲喜保宁多少钱一盒?
It is an anti-epileptic drug and is clinically used to treat epilepsy in which other anti-epileptic drugs are ineffective, especially partial seizures. It can also treat infantile spasms (West syndrome, West syndrome). Vigabatrin's generic name is vigabatrin and its brand name is Sabril. It is a drug used to treat epilepsy and infantile spasms. It was developed in the 1980s. The treatment was approved in the UK in 1989. On August 21, 2009, the U.S. FDA approved Sabril as a monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjunctive (additional) treatment for adult patients with refractory complex partial epilepsy (CPS). Vigabatrin is a synthetic derivative of gamma-aminobutyric acid (GABA), which increases the concentration of the inhibitory neurotransmitter GABA in the brain by irreversibly inhibiting GABA aminotransferase. It can increase the level of GABA in the human brain as the activity of GABA aminotransferase continues to decrease rapidly, and there is an obvious dose-effect relationship. Studies have shown that after administration of this drug, the concentration of GABA in the brains of rodents and in the cerebrospinal fluid of humans increases, and the degree of increase is related to the dose.
Sanofi (NYSE: SNY) was founded in 1973. Its predecessor was Sanofi-Aventis. It was changed to its current name: Sanofi in May 2011. It is headquartered in Paris, France, and has 113,496 full-time employees in more than 100 countries around the world. It is the world's leading diversified pharmaceutical and health company with diversified products, including drugs, vaccines and innovative treatment solutions. So, how much does a box of Sanofi Vigabatrin cost? It is understood that Sanofi's specifications are 500mg*100 capsules/box, and the price is equivalent to about RMB 1,450. It is currently the most worthy version for patients to choose.
Recommended related hot articles: /newsDetail/89925.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)